Location History:
- Sollihogda, NO (1991 - 2000)
- Oslo, NO (2005)
Company Filing History:
Years Active: 1991-2005
Title: The Innovations of Peter Alestrom
Introduction
Peter Alestrom is a notable inventor based in Sollihogda, Norway. He has made significant contributions to the field of biotechnology, particularly in the production of human parathyroid hormone from microorganisms. With a total of 4 patents, Alestrom's work has advanced the understanding and application of recombinant DNA technology.
Latest Patents
One of Alestrom's latest patents focuses on the production of human parathyroid hormone from microorganisms. This invention provides recombinant plasmids containing DNA sequences that code for human preproparathyroid hormone. The invention further details microorganisms, such as E. coli, that are transformed by these plasmids. Additionally, it includes a plasmid designed for insertion into yeast, resulting in a transformed yeast that secretes parathyroid hormone. The patent also discusses alternate polypeptides with parathyroid hormone activity, including PTH analogs, fragments, and extensions. Furthermore, it provides various leader sequences and secretion signal sequences that can be utilized in this process. Finally, methods for the purification of the secreted PTH hormone and its derivatives are also outlined.
Career Highlights
Throughout his career, Peter Alestrom has worked with several companies, including NPS Allelix Corporation and Selmer-Sande, A.S. His experience in these organizations has contributed to his expertise in biotechnology and patent development.
Collaborations
Alestrom has collaborated with notable individuals in his field, including Kaare M. Gautvik and Odd Stokke Gabrielsen. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Peter Alestrom's contributions to biotechnology, particularly in the production of human parathyroid hormone, highlight his innovative spirit and dedication to advancing science. His patents and collaborations reflect a commitment to improving health outcomes through technological advancements.